Modification of tumor cells by a low dose of Newcastle Disease Virus.

Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

1983 • 1,307 citations

Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

1981 • 1,281 citations

In vitro methods in cell-mediated and tumor immunity

1976 • 1,266 citations

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1984 • 884 citations

IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

1980 • 835 citations

Ordered Hypotheses for Multiple Treatments: A Significance Test for Linear Ranks

1963 • 647 citations

NK Cells and Other Natural Effector Cells

1982 • 624 citations

Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells

1985 • 613 citations

Thymoma production of T cell growth factor (Interleukin 2).

1980 • 487 citations

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

1985 • 410 citations

Regulatory Effect of Interferon on T Cells in Vitro

1976 • 181 citations

Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies

1983 • 168 citations

Antigenic Tumor Cell Variants Obtained with Mutagens

1983 • 166 citations

Interferon Production by Inactivated Newcastle Disease Virus in Cell Cultures and in Mice

1966 • 130 citations

A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies

1985 • 120 citations

Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes

1979 • 115 citations

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects

1986 • 109 citations

Evidence for an increase in cosmogenic 10Be during a geomagnetic reversal

1985 • 100 citations

Antigenic variation in cancer metastasis: immune escape versus immune control

1982 • 95 citations

Gangliosides as Paramyxovirus Receptor. Structural Requirement of Sialo-Oligosaccharides in Receptors for Hemagglutinating Virus of Japan (Sendai Virus) and Newcastle Disease Virus

1985 • 88 citations

Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.

1984 • 85 citations

Enumeration of IL 2-secreting helper T cells by limiting dilution analysis, and demonstration of unexpectedly high levels of IL 2 production per responding cell.

1982 • 77 citations

The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.

1980 • 73 citations

Viral Xenogenization of Intact Tumor Cells

1979 • 71 citations

Virus Augmentation of The Antigenicity of Tumor Cell

1979 • 64 citations

Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes.

1981 • 64 citations

Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti‐tumor immunity in vivo and of cytolytic T cells in vitro

1979 • 58 citations

The augmentation of tumor‐specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus‐reactive helper T cells

1984 • 56 citations

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity

1987 • 56 citations

Limiting Dilution Assays for the Separation, Characterization, and Quantitation of Biologically Active Particles and Their Clonal Progeny

1987 • 54 citations

CD4⁺ helper T cells are required for resistance to a highly metastatic murine tumor

1987 • 53 citations

Associative Control of the Immune Response to Cell Surface Antigens

1976 • 44 citations

Interleukin 2 is not sufficient as helper component for the activation of cytotoxic T lymphocytes but synergizes with a late helper effect that is provided by irradiated I-region-incompatible stimulator cells.

1982 • 36 citations

Cell surface modification in the treatment of experimental cancer: Neuraminidase or concanavalin a

1974 • 34 citations

Release of discrete interferons by cytotoxic T lymphocytes in response to immune and nonimmune stimuli.

1984 • 29 citations

How T cells communicate

1987 • 26 citations

Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.

1984 • 26 citations

Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.

1985 • 26 citations

Control of immune interferon release by cytotoxic T-cell clones specific for influenza.

1985 • 25 citations

Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune responses to virus-associated antigens produced on immunizing cells.

1983 • 25 citations

Newcastle Disease Virus: the Effect of Monoclonal Antibody in the Overlay on Virus Penetration and the Immunoselection of Variants

1984 • 24 citations

Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount anti-tumour responses to PPD-coupled tumour cells.

1984 • 24 citations

A method for testing the specificity of influenza A virus-reactive memory cytotoxic T lymphocyte (CTL) clones in limiting dilution cultures

1984 • 23 citations

Interferon Production in Mouse Spleen Cells and Mouse Fibroblasts (L Cells) Stimulated by Various Strains of Newcastle Disease Virus

1982 • 22 citations

New antigens presented on tumor cells can cause immune rejection without influencing the frequency of tumor-specific cytolytic T cells

1987 • 21 citations

Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.

1984 • 19 citations

The augmentation of tumor-specific immunity by virus help

1986 • 19 citations

The biological modification of tumor cells as a means of inducing their regression: an overview.

1986 • 17 citations

Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction and cytotoxic response.

1981 • 17 citations

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. III. Postoperative activation of tumor-specific CTLP from mice with metastases requires stimulation with the specific antigen plus additional signals.

1989 • 17 citations

On the possibility of intercalation of aromatic amino acid residues into double-stranded DNA helix

1974 • 16 citations

Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.

1986 • 16 citations

Strategies for cell-mediated immunotherapy of cancer: killing or help?

1986 • 13 citations

Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigens.

1985 • 13 citations

T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.

1985 • 12 citations

Somatic H‐2K^k variants reveal nonidentity of serological and cytotoxic T cell‐defined K^k determinants

1983 • 12 citations

Evaluation of in vivo and in vitro effectivity of immune defense against a spontaneously arising, nonlymphoid rat tumor

1985 • 12 citations

AUGMENTATION OF HUMAN NATURAL KILLER CELLS WITH HUMAN LEUKOCYTE AND HUMAN RECOMBINANT LEUKOCYTE INTERFERON

1982 • 10 citations

Effect of Interferon on Cell Proliferation and Generation of Cytotoxic Potential in Mixed Autologous and Allogeneic Lymphocyte Cultures

1983 • 10 citations

Virus‐Dependent Cellular Cytotoxicity in Vitro

1985 • 8 citations

Production of type I (α/β) interferon after virus infection of cloned, alloantigen‐sensitized mouse T lymphocytes

1984 • 8 citations

Tumor immunity and autoimmunity produced by injection of antigens modified by adsorbed virus

1980 • 5 citations

Cited By (0)

Loading...